Education/CredentialsFellowship: University of Washington (Gastroenterology)Internship: University of WashingtonMedical Degree: University of WashingtonBachelor's Degree: Washington State University (Genetics and Cell Biology) Board Certifications & LicensesAmerican Board of Internal Medicine (Gastroenterology) (Certification Date: 2013-11-20) - (Recertification Date: 2019-07-12) LanguagesFarsi SpecialtiesDigestive DiseasesInternal Medicine Contact Information Medical Sciences Building Office 513-558-4664 Email afzaliaa@ucmail.uc.edu Clinical Interests Gastroenterology Peer Reviewed Publications Afzali, Anita; Lukanova, Rina; Hennessy, Fritha; Kakehi, Sumie; Knight, Hannah; Milligan, Gary; Gupte-Singh, Komal 2023. Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States. Advances in therapy, 40 10, 4321-4338Clement, Benjamin; De Felice, Kara; Afzali, Anita 2023. Indications and safety of newer IBD treatments in the older patient. Current gastroenterology reports, 25 7, 160-168Danese, Silvio; Panaccione, Remo; Abreu, Maria T; Rubin, David T; Ghosh, Subrata; Dignass, Axel; Afzali, Anita; Wolf, Douglas C; Chiorean, Michael V; Vermeire, Severine; Jain, Anjali; Charles, Lorna; Lawlor, Garrett; Osterman, Mark T; Wu, Hsiuanlin; Canavan, James B; Petersen, Ann Katrin; Colombel, Jean-Frederic; Regueiro, Miguel 2023. Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension. Journal of Crohn's & colitis, , Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R 2023. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. The lancet. Gastroenterology & hepatology, , Herfarth, Hans H; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree G; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Long, Millie D 2023. Clinical long-term outcomes of patient-reported outcomes in the prospective real-world Tofacitinib Response in Ulcerative Colitis (TOUR) registry: Tofacitinib Response in Ulcerative Colitis (TOUR). Clinical and translational gastroenterology, , Johnson, Amanda M; Barsky, Maria; Ahmed, Waseem; Zullow, Samantha; Galati, Jonathan; Jairath, Vipul; Narula, Neeraj; Peerani, Farhad; Click, Benjamin H; Coburn, Elliot S; Dang, ThucNhi Tran; Gold, Stephanie; Agrawal, Manasi; Garg, Rajat; Aggarwal, Manik; Mohammad, Danah; Halloran, Brendan; Kochhar, Gursimran S; Todorowski, Hannah; Ud Din, Nabeeha Mohy; Izanec, James; Teeple, Amanda; Gasink, Chris; Muser, Erik; Ding, Zhijie; Swaminath, Arun; Lakhani, Komal; Hogan, Dan; Datta, Samit; Ungaro, Ryan C; Boland, Brigid S; Bohm, Matthew; Fischer, Monika; Sagi, Sashidhar; Afzali, Anita; Ullman, Thomas; Lawlor, Garrett; Baumgart, Daniel C; Chang, Shannon; Hudesman, David; Lukin, Dana; Scherl, Ellen J; Colombel, Jean-Frederic; Sands, Bruce E; Siegel, Corey A; Regueiro, Miguel; Sandborn, William J; Bruining, David; Kane, Sunanda; Loftus, Edward V; Dulai, Parambir S 2023. The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. The American journal of gastroenterology, 118 2, 317-328Long, Millie D; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Sharma, Puza P; Herfarth, Hans H 2023. Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Inflammatory bowel diseases, 29 4, 570-578Allen, Kenneth D; Kiefer, Miranda K; Butnariu, Madalina; Afzali, Anita 2022. Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Archives of gynecology and obstetrics, 306 6, 1929-1937Axelrad, Jordan; Long, Millie; Horst, Sara; Afzali, Anita; Sapir, Tamar; Fajardo, Kristina; De Felice, Kara; Sandler, Robert; Cross, Raymond 2022. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols, 11 12, e40382Dulai, Parambir S; Rai, Victoria; Raffals, Laura E; Lukin, Dana; Hudesman, David; Kochhar, Gursimran S; Damas, Oriana M; Sauk, Jenny S; Levy, Alexander N; Sofia, M Anthony; Tuskey, Anne; Deepak, Parakkal; Yarur, Andres J; Afzali, Anita; Ananthakrishnan, Ashwin N; Cross, Raymond K; Hanauer, Stephen B; Siegel, Corey A 2022. Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. The American journal of gastroenterology, 117 8, 1288-1295Feagan, Brian G; Schreiber, Stefan; Afzali, Anita; Rieder, Florian; Hyams, Jeffrey; Kollengode, Kanthi; Pearlman, Jared; Son, Vladimir; Marta, Cecilia; Wolf, Douglas C; D'Haens, Geert G 2022. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemporary clinical trials, 122 , 106958Neyazi, Narges; Safi, Najibullah; Afzali, Anita; Kabir, Misha 2022. Gender barriers are worsening women's access to health care in Afghanistan. Lancet (London, England), 400 10354, 731-732Pusateri, Antoinette; Anaizi, Ahmad; Nemer, Laura; Hinton, Alice; Lara, Luis; Afzali, Anita 2022. Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis. Crohn's & colitis 360, 4 2, otac015Sandborn, William J; D'Haens, Geert R; Reinisch, Walter; Panés, Julián; Chan, Daphne; Gonzalez, Susana; Weisel, Kathleen; Germinaro, Matthew; Frustaci, Mary Ellen; Yang, Zijiang; Adedokun, Omoniyi J; Han, Chenglong; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; Rubin, David T; Sands, Bruce E; Afzali, Anita; Andrews, Jane M; Feagan, Brian G 2022. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology, 162 6, 1650-1664.e8Afzali, Anita; Furtner, Daniel; Melsheimer, Richard; Molloy, Philip J 2021. The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable. Advances in therapy, 38 5, 2077-2093Balzora, Sophie; Afzali, Anita; Bewtra, Meenakshi 2021. Social Media-The Next Glass Ceiling? Gastroenterology, 161 1, 373-374Hemperly, Amy; Dubinsky, Marla C; Yarur, Andres; Afzali, Anita; Hanauer, Stephen; Kugathasan, Subra; Long, Millie D; Rabizadeh, Shervin; Sockolow, Robbyn; Okada, Lauren; Jain, Anjali; Abreu, Maria T; Vande Casteele, Niels 2021. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn's & colitis 360, 3 3, otab035Pearlstein, Haley; Bricker, Josh; Michel, Hilary K; Afzali, Anita; Donegan, Amy M; Maltz, Ross M; Boyle, Brendan M; Dotson, Jennifer L 2021. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition, 72 4, 563-568Pusateri, Antoinette; Hatcher, Ashley; Patel, Nisha; Lehman, Joy; Hinton, Alice; Afzali, Anita 2021. Impact of rapid infliximab infusions on access at a large academic tertiary medical center. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 78 22, 2046-2052Rubin, David T; Sninsky, Charles; Siegmund, Britta; Sans, Miquel; Hart, Ailsa; Bressler, Brian; Bouhnik, Yoram; Armuzzi, Alessandro; Afzali, Anita 2021. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflammatory bowel diseases, 27 12, 1942-1953Syal, Gaurav; Serrano, Mariastella; Jain, Animesh; Cohen, Benjamin L; Rieder, Florian; Stone, Christian; Abraham, Bincy; Hudesman, David; Malter, Lisa; McCabe, Robert; Holubar, Stefan; Afzali, Anita; Cheifetz, Adam S; Gaidos, Jill K J; Moss, Alan C 2021. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases, 27 10, 1552-1563Chiorean, Michael; Afzali, Anita; Cross, Raymond K; Macaulay, Dendy; Griffith, Jenny; Wang, Anthony; Garcia-Horton, Viviana 2020. Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab. Crohn's & colitis 360, 2 2, otaa031Clark-Snustad, Kindra; Butnariu, Madalina; Afzali, Anita 2020. Women's Health and Ulcerative Colitis. Gastroenterology clinics of North America, 49 4, 769-789McMahon, Kevin R; Allen, Kenneth D; Afzali, Anita; Husain, Syed 2020. Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 24 1, 88-97Afzali, Anita 2019. Inflammatory bowel disease during pregnancy: management of a disease flare or remission. Current opinion in gastroenterology, 35 4, 281-287Afzali, Anita 2019. Update on Pregnancy in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, 15 6, 313-315Alley, Kristen; Singla, Anand; Afzali, Anita 2019. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Inflammatory bowel diseases, 25 12, 1990-1995Chen, Tong; Shi, Ni; Afzali, Anita 2019. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease. Nutrients, 11 6, Kruger, Andrew J; Hinton, Alice; Afzali, Anita 2019. To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients. Inflammatory bowel diseases, 25 7, e74-e76Kruger, Andrew J; Hinton, Alice; Afzali, Anita 2019. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients. Inflammatory bowel diseases, 25 5, 894-901Menon, Tara; Afzali, Anita 2019. Immune-Mediated Colitis. Current treatment options in gastroenterology, 17 4, 506-523Menon, Tara; Afzali, Anita 2019. Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care. The American journal of gastroenterology, 114 9, 1432-1440Sobotka, Lindsay A; Crilley, Tessa; Levine, Edward; Afzali, Anita 2019. Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers. ACG case reports journal, 6 7, e00153Afzali, Anita; Katz, Seymour 2018. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Current treatment options in gastroenterology, 16 3, 289-305Clowse, Megan E B; Scheuerle, Angela E; Chambers, Christina; Afzali, Anita; Kimball, Alexa B; Cush, John J; Cooney, Maureen; Shaughnessy, Laura; Vanderkelen, Mark; Förger, Frauke 2018. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Arthritis & rheumatology (Hoboken, N.J.), 70 9, 1399-1407Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V 2017. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflammatory bowel diseases, 24 1, 2-4Afzali, Anita; Ogden, Kristine; Friedman, Michael L; Chao, Jingdong; Wang, Anthony 2017. Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting. Journal of medical economics, 20 4, 409-422Afzali, Anita; Sinanan, Mika N; Lee, Scott D 2017. Reply. Inflammatory bowel diseases, 23 1, E3Afzali, Anita; Wahbeh, Ghassan 2017. Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3? World journal of gastroenterology, 23 20, 3624-3631Sandborn, William J; Wolf, Douglas C; Kosutic, Gordana; Parker, Gerry; Schreiber, Stefan; Lee, Scott D; Abraham, Bincy; Afzali, Anita; Arsenescu, Razvan I; Gutierrez, Alexandra; Spearman, Marshall; Coarse, Jason; Feagan, Brian G 2017. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. Inflammatory bowel diseases, 23 7, 1047-1056Afzali, Anita; Cross, Raymond K 2016. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflammatory bowel diseases, 22 8, 2023-40Afzali, Anita; Park, Christopher J; Zhu, Kehao; Hu, Jie Kate; Sharma, Prachi; Sinanan, Mika N; Lee, Scott D 2016. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 22 8, 1887-95Fausel, Rebecca; Afzali, Anita 2015. Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists. Therapeutics and clinical risk management, 11 , 63-73Afzali, Anita; Wheat, Chelle L; Hu, Jie Kate; Olerud, John E; Lee, Scott D 2014. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. Journal of Crohn's & colitis, 8 6, 480-8Kelly, Colleen R; Ihunnah, Chioma; Fischer, Monika; Khoruts, Alexander; Surawicz, Christina; Afzali, Anita; Aroniadis, Olga; Barto, Amy; Borody, Thomas; Giovanelli, Andrea; Gordon, Shelley; Gluck, Michael; Hohmann, Elizabeth L; Kao, Dina; Kao, John Y; McQuillen, Daniel P; Mellow, Mark; Rank, Kevin M; Rao, Krishna; Ray, Arnab; Schwartz, Margot A; Singh, Namita; Stollman, Neil; Suskind, David L; Vindigni, Stephen M; Youngster, Ilan; Brandt, Lawrence 2014. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American journal of gastroenterology, 109 7, 1065-71Afzali, Anita; Berry, Kristin; Ioannou, George N 2012. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 18 1, 29-37Wolf, Douglas C; Abraham, Bincy P; Afzali, Anita; Allegretti, Paul D; Arai, Ronen 2012. Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC. Gastroenterology & hepatology, 8 6 Suppl 2, 1-16Afzali, Anita; Weiss, Noel S; Boyko, Edward J; Ioannou, George N 2010. Association between serum uric acid level and chronic liver disease in the United States. Hepatology (Baltimore, Md.), 52 2, 578-89 Axelrad J.; Long M.; Horst S.; Afzali A.; Sapir T.; Fajardo K.; De Felice K.; Sandler R.; Cross R. 12-01-2022. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With JMIR Research Protocols, 11 12, O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. 08-01-2016. Update on MR Enterography: Potentials and Pitfalls Current Radiology Reports, 4 8, O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. 08-01-2016. Update on MR Enterography: Potentials and Pitfalls Current Radiology Reports, 4 8, Hemperly A.; Dubinsky M.C.; Yarur A.; Afzali A.; Hanauer S.; Kugathasan S.; Long M.D.; Rabizadeh S.; Sockolow R.; Okada L.; Jain A.; Abreu M.T.; Vande Casteele N. 07-01-2021. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Crohn's and Colitis 360, 3 3, 1-8 Sands B.E.; Irving P.M.; Hoops T.; Izanec J.L.; Gao L.L.; Gasink C.; Greenspan A.; Allez M.; Danese S.; Hanauer S.B.; Jairath V.; Kuehbacher T.; Lewis J.D.; Loftus E.V.; Mihaly E.; Mihaly E.; Panaccione R.; Scherl E.; Shchukina O.B.; Sandborn W.J.; Afzali A.; Aitova L.; Aldeguer i Mante X.; Altorjay I.; Argüelles Arias F.; Armuzzi A.; Augustyn M.; Bafutto M.; Barrio J.; Begun J.; Behrend C.; Bezemer G.; Bonnaud G.; Brankovic M.; Byung I.J.; Calvet Calvo X.; Chachu K.; Chebli J.M.F.; Cheon J.H.; Cichoz-Lach H.; Clark L.; Cummings F.; Dalal K.; De Boer N.; De Lourdes Ferrari M.; Désilets E.; Dugalic P.; Duvall G.; Fedorishina O.; Filip R.; Flores C.; Fogel R.; Fon J.; Frankel M.; Friedenberg K.; Fries W.; Galina V.; Gietka P.; Goel R.; Hasselblatt P.; Herfarth H.; Herszényi L.; Hindryckx P.; Hoentjen F.; Horjus Talabur Horje C.; Iduru S.; Isfort R.; Jones M.; Kalimullina D.; Katz J.; Kaur M.; Khurana S.K.; Kim J.S.; Kim Y.; Kleczkowski D.; Knezevic S.; Knoll A.; Korman L.Y.; Kotzev I.; Kulyapin A.; Lee K.M.; Leemreis D.; Leszczyszyn J.; Limdi J.; Lissauer J.; Loftus E.; Malecka-Panas E.; Marshall J.; Milan L.; Monteleone G.; Nagorni A.; Owczarek D.; Palekar N.; Park Y.S.; Park S.H.; Parra R.; Patai Á.; Patel K.; Patel B.; Pershko A. 06-11-2022. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with The Lancet, 399 10342, 2200-2211 Afzali A.; Carlson C.; Lee S.; Wheat C. 06-01-2012. 31-Year-old male with frequent bleeding and portal vein thrombosis Gastroenterology and Hepatology, 8 6, 8-10 Afzali A.; Carlson C.; Lee S.; Wheat C. 06-01-2012. 31-Year-old male with frequent bleeding and portal vein thrombosis Gastroenterology and Hepatology, 8 6, 8-10 Tiderington E.; Afzali Md A. 05-01-2018. A practical approach to management of the patient with inflammatory bowel disease following tumor ne Journal of Clinical Outcomes Management, 25 5, Tiderington E.; Afzali Md A. 05-01-2018. A practical approach to management of the patient with inflammatory bowel disease following tumor ne Journal of Clinical Outcomes Management, 25 5, Pusateri A.; Anaizi A.; Nemer L.; Hinton A.; Lara L.; Afzali A. 04-01-2022. Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recre Crohn's and Colitis 360, 4 2, Chiorean M.; Afzali A.; Cross R.K.; Macaulay D.; Griffith J.; Wang A.; Garcia-Horton V. 04-01-2020. Economic outcomes of inflammatory bowel disease patients switching to a second anti-tumor necrosis f Crohn's and Colitis 360, 2 2, Danese S.; Panaccione R.; Feagan B.G.; Afzali A.; Rubin D.T.; Sands B.E.; Reinisch W.; Panés J.; Sahoo A.; Terry N.A.; Chan D.; Han C.; Frustaci M.E.; Yang Z.; Sandborn W.J.; Hisamatsu T.; Andrews J.M.; D'Haens G.R.; Oliinyk O.; Bilianskyi L.; Gniady-Jastrzebska J.; Petryka R.; Arlukowicz T.; Gietka P.; Zmudzinski M.; Mumtaz S.; Wolf D.; Wojcik K.; Duvall G.; Augustyn M.; Filip R.; Tarabar D.; Tkachev A.; Seidler U.; Zittan E.; Pokrotnieks J.; Shchukina O.; Machavariani A.; Loy L.; Abu-farsakh N.; Marina P.; Sreckovic S.; Laclav M.; Wei S.C.; Suiter D.; Borsuk A.; Hebuterne X.; Buning C.; Lahat-Zok A.; Danilkiewicz W.; Frysna B.; Jovicic I.; Datsenko O.; Guram M.; Jain A.; Rashid Z.; Heeren S.; Shulga N.; Timkin I.; Gornjakovic S.; Lukas M.; Altwegg R.; Desjeux A.; Reimund J.M.; Giorgadze M.; Jochum C.; Ito H.; Nakai K.; Takagi T.; Zaha O.; Choi C.; Kim T.; Lee J.; Stundiene I.; Hilmi I.N.; Hj Md Said R.; Leszczyszyn J.; Abdulganieva D.; Fominykh Y.; Maksyashina S.; Balaz J.; Van Domselaar M.; Kav T.; Dennis P.; Henry P.; Holmes R.; Johnson C.; McBride M.; Sarles H.; Moore G.; Yakubtsevich R.; Muls V.; Trbojevic S.; Afif W.; Bernstein C.; Klarin I.; Serclova Z.; Volfova M.; Desreumaux P.; Gilletta de Saint Joseph C. 01-01-2023. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results The Lancet Gastroenterology and Hepatology, , Afzali A. 01-01-2019. Update on pregnancy in patients with inflammatory bowel disease Gastroenterology and Hepatology, 15 6, 313-315 Afzali A. 01-01-2019. Update on pregnancy in patients with inflammatory bowel disease Gastroenterology and Hepatology, 15 6, 313-315 Fausel R.; Afzali A.; Afzali A. 01-01-2015. Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon Therapeutics and Clinical Risk Management, 11 , 63-72 Fausel R.; Afzali A.; Afzali A. 01-01-2015. Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon Therapeutics and Clinical Risk Management, 11 , 63-72 Afzali A.; Wheat C.L.; Lee S.D. 01-01-2014. Oral and parenteral corticosteroid therapy in ulcerative colitis Medical Therapy of Ulcerative Colitis, , 111-120 Afzali A.; Wheat C.L.; Lee S.D. 01-01-2014. Oral and parenteral corticosteroid therapy in ulcerative colitis Medical Therapy of Ulcerative Colitis, , 111-120
Peer Reviewed Publications Afzali, Anita; Lukanova, Rina; Hennessy, Fritha; Kakehi, Sumie; Knight, Hannah; Milligan, Gary; Gupte-Singh, Komal 2023. Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States. Advances in therapy, 40 10, 4321-4338Clement, Benjamin; De Felice, Kara; Afzali, Anita 2023. Indications and safety of newer IBD treatments in the older patient. Current gastroenterology reports, 25 7, 160-168Danese, Silvio; Panaccione, Remo; Abreu, Maria T; Rubin, David T; Ghosh, Subrata; Dignass, Axel; Afzali, Anita; Wolf, Douglas C; Chiorean, Michael V; Vermeire, Severine; Jain, Anjali; Charles, Lorna; Lawlor, Garrett; Osterman, Mark T; Wu, Hsiuanlin; Canavan, James B; Petersen, Ann Katrin; Colombel, Jean-Frederic; Regueiro, Miguel 2023. Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension. Journal of Crohn's & colitis, , Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R 2023. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. The lancet. Gastroenterology & hepatology, , Herfarth, Hans H; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree G; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Long, Millie D 2023. Clinical long-term outcomes of patient-reported outcomes in the prospective real-world Tofacitinib Response in Ulcerative Colitis (TOUR) registry: Tofacitinib Response in Ulcerative Colitis (TOUR). Clinical and translational gastroenterology, , Johnson, Amanda M; Barsky, Maria; Ahmed, Waseem; Zullow, Samantha; Galati, Jonathan; Jairath, Vipul; Narula, Neeraj; Peerani, Farhad; Click, Benjamin H; Coburn, Elliot S; Dang, ThucNhi Tran; Gold, Stephanie; Agrawal, Manasi; Garg, Rajat; Aggarwal, Manik; Mohammad, Danah; Halloran, Brendan; Kochhar, Gursimran S; Todorowski, Hannah; Ud Din, Nabeeha Mohy; Izanec, James; Teeple, Amanda; Gasink, Chris; Muser, Erik; Ding, Zhijie; Swaminath, Arun; Lakhani, Komal; Hogan, Dan; Datta, Samit; Ungaro, Ryan C; Boland, Brigid S; Bohm, Matthew; Fischer, Monika; Sagi, Sashidhar; Afzali, Anita; Ullman, Thomas; Lawlor, Garrett; Baumgart, Daniel C; Chang, Shannon; Hudesman, David; Lukin, Dana; Scherl, Ellen J; Colombel, Jean-Frederic; Sands, Bruce E; Siegel, Corey A; Regueiro, Miguel; Sandborn, William J; Bruining, David; Kane, Sunanda; Loftus, Edward V; Dulai, Parambir S 2023. The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. The American journal of gastroenterology, 118 2, 317-328Long, Millie D; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Sharma, Puza P; Herfarth, Hans H 2023. Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Inflammatory bowel diseases, 29 4, 570-578Allen, Kenneth D; Kiefer, Miranda K; Butnariu, Madalina; Afzali, Anita 2022. Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Archives of gynecology and obstetrics, 306 6, 1929-1937Axelrad, Jordan; Long, Millie; Horst, Sara; Afzali, Anita; Sapir, Tamar; Fajardo, Kristina; De Felice, Kara; Sandler, Robert; Cross, Raymond 2022. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols, 11 12, e40382Dulai, Parambir S; Rai, Victoria; Raffals, Laura E; Lukin, Dana; Hudesman, David; Kochhar, Gursimran S; Damas, Oriana M; Sauk, Jenny S; Levy, Alexander N; Sofia, M Anthony; Tuskey, Anne; Deepak, Parakkal; Yarur, Andres J; Afzali, Anita; Ananthakrishnan, Ashwin N; Cross, Raymond K; Hanauer, Stephen B; Siegel, Corey A 2022. Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. The American journal of gastroenterology, 117 8, 1288-1295Feagan, Brian G; Schreiber, Stefan; Afzali, Anita; Rieder, Florian; Hyams, Jeffrey; Kollengode, Kanthi; Pearlman, Jared; Son, Vladimir; Marta, Cecilia; Wolf, Douglas C; D'Haens, Geert G 2022. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemporary clinical trials, 122 , 106958Neyazi, Narges; Safi, Najibullah; Afzali, Anita; Kabir, Misha 2022. Gender barriers are worsening women's access to health care in Afghanistan. Lancet (London, England), 400 10354, 731-732Pusateri, Antoinette; Anaizi, Ahmad; Nemer, Laura; Hinton, Alice; Lara, Luis; Afzali, Anita 2022. Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis. Crohn's & colitis 360, 4 2, otac015Sandborn, William J; D'Haens, Geert R; Reinisch, Walter; Panés, Julián; Chan, Daphne; Gonzalez, Susana; Weisel, Kathleen; Germinaro, Matthew; Frustaci, Mary Ellen; Yang, Zijiang; Adedokun, Omoniyi J; Han, Chenglong; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; Rubin, David T; Sands, Bruce E; Afzali, Anita; Andrews, Jane M; Feagan, Brian G 2022. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology, 162 6, 1650-1664.e8Afzali, Anita; Furtner, Daniel; Melsheimer, Richard; Molloy, Philip J 2021. The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable. Advances in therapy, 38 5, 2077-2093Balzora, Sophie; Afzali, Anita; Bewtra, Meenakshi 2021. Social Media-The Next Glass Ceiling? Gastroenterology, 161 1, 373-374Hemperly, Amy; Dubinsky, Marla C; Yarur, Andres; Afzali, Anita; Hanauer, Stephen; Kugathasan, Subra; Long, Millie D; Rabizadeh, Shervin; Sockolow, Robbyn; Okada, Lauren; Jain, Anjali; Abreu, Maria T; Vande Casteele, Niels 2021. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn's & colitis 360, 3 3, otab035Pearlstein, Haley; Bricker, Josh; Michel, Hilary K; Afzali, Anita; Donegan, Amy M; Maltz, Ross M; Boyle, Brendan M; Dotson, Jennifer L 2021. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition, 72 4, 563-568Pusateri, Antoinette; Hatcher, Ashley; Patel, Nisha; Lehman, Joy; Hinton, Alice; Afzali, Anita 2021. Impact of rapid infliximab infusions on access at a large academic tertiary medical center. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 78 22, 2046-2052Rubin, David T; Sninsky, Charles; Siegmund, Britta; Sans, Miquel; Hart, Ailsa; Bressler, Brian; Bouhnik, Yoram; Armuzzi, Alessandro; Afzali, Anita 2021. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflammatory bowel diseases, 27 12, 1942-1953Syal, Gaurav; Serrano, Mariastella; Jain, Animesh; Cohen, Benjamin L; Rieder, Florian; Stone, Christian; Abraham, Bincy; Hudesman, David; Malter, Lisa; McCabe, Robert; Holubar, Stefan; Afzali, Anita; Cheifetz, Adam S; Gaidos, Jill K J; Moss, Alan C 2021. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases, 27 10, 1552-1563Chiorean, Michael; Afzali, Anita; Cross, Raymond K; Macaulay, Dendy; Griffith, Jenny; Wang, Anthony; Garcia-Horton, Viviana 2020. Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab. Crohn's & colitis 360, 2 2, otaa031Clark-Snustad, Kindra; Butnariu, Madalina; Afzali, Anita 2020. Women's Health and Ulcerative Colitis. Gastroenterology clinics of North America, 49 4, 769-789McMahon, Kevin R; Allen, Kenneth D; Afzali, Anita; Husain, Syed 2020. Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 24 1, 88-97Afzali, Anita 2019. Inflammatory bowel disease during pregnancy: management of a disease flare or remission. Current opinion in gastroenterology, 35 4, 281-287Afzali, Anita 2019. Update on Pregnancy in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, 15 6, 313-315Alley, Kristen; Singla, Anand; Afzali, Anita 2019. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Inflammatory bowel diseases, 25 12, 1990-1995Chen, Tong; Shi, Ni; Afzali, Anita 2019. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease. Nutrients, 11 6, Kruger, Andrew J; Hinton, Alice; Afzali, Anita 2019. To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients. Inflammatory bowel diseases, 25 7, e74-e76Kruger, Andrew J; Hinton, Alice; Afzali, Anita 2019. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients. Inflammatory bowel diseases, 25 5, 894-901Menon, Tara; Afzali, Anita 2019. Immune-Mediated Colitis. Current treatment options in gastroenterology, 17 4, 506-523Menon, Tara; Afzali, Anita 2019. Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care. The American journal of gastroenterology, 114 9, 1432-1440Sobotka, Lindsay A; Crilley, Tessa; Levine, Edward; Afzali, Anita 2019. Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers. ACG case reports journal, 6 7, e00153Afzali, Anita; Katz, Seymour 2018. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Current treatment options in gastroenterology, 16 3, 289-305Clowse, Megan E B; Scheuerle, Angela E; Chambers, Christina; Afzali, Anita; Kimball, Alexa B; Cush, John J; Cooney, Maureen; Shaughnessy, Laura; Vanderkelen, Mark; Förger, Frauke 2018. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Arthritis & rheumatology (Hoboken, N.J.), 70 9, 1399-1407Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V 2017. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflammatory bowel diseases, 24 1, 2-4Afzali, Anita; Ogden, Kristine; Friedman, Michael L; Chao, Jingdong; Wang, Anthony 2017. Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting. Journal of medical economics, 20 4, 409-422Afzali, Anita; Sinanan, Mika N; Lee, Scott D 2017. Reply. Inflammatory bowel diseases, 23 1, E3Afzali, Anita; Wahbeh, Ghassan 2017. Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3? World journal of gastroenterology, 23 20, 3624-3631Sandborn, William J; Wolf, Douglas C; Kosutic, Gordana; Parker, Gerry; Schreiber, Stefan; Lee, Scott D; Abraham, Bincy; Afzali, Anita; Arsenescu, Razvan I; Gutierrez, Alexandra; Spearman, Marshall; Coarse, Jason; Feagan, Brian G 2017. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. Inflammatory bowel diseases, 23 7, 1047-1056Afzali, Anita; Cross, Raymond K 2016. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflammatory bowel diseases, 22 8, 2023-40Afzali, Anita; Park, Christopher J; Zhu, Kehao; Hu, Jie Kate; Sharma, Prachi; Sinanan, Mika N; Lee, Scott D 2016. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 22 8, 1887-95Fausel, Rebecca; Afzali, Anita 2015. Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists. Therapeutics and clinical risk management, 11 , 63-73Afzali, Anita; Wheat, Chelle L; Hu, Jie Kate; Olerud, John E; Lee, Scott D 2014. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. Journal of Crohn's & colitis, 8 6, 480-8Kelly, Colleen R; Ihunnah, Chioma; Fischer, Monika; Khoruts, Alexander; Surawicz, Christina; Afzali, Anita; Aroniadis, Olga; Barto, Amy; Borody, Thomas; Giovanelli, Andrea; Gordon, Shelley; Gluck, Michael; Hohmann, Elizabeth L; Kao, Dina; Kao, John Y; McQuillen, Daniel P; Mellow, Mark; Rank, Kevin M; Rao, Krishna; Ray, Arnab; Schwartz, Margot A; Singh, Namita; Stollman, Neil; Suskind, David L; Vindigni, Stephen M; Youngster, Ilan; Brandt, Lawrence 2014. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American journal of gastroenterology, 109 7, 1065-71Afzali, Anita; Berry, Kristin; Ioannou, George N 2012. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 18 1, 29-37Wolf, Douglas C; Abraham, Bincy P; Afzali, Anita; Allegretti, Paul D; Arai, Ronen 2012. Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC. Gastroenterology & hepatology, 8 6 Suppl 2, 1-16Afzali, Anita; Weiss, Noel S; Boyko, Edward J; Ioannou, George N 2010. Association between serum uric acid level and chronic liver disease in the United States. Hepatology (Baltimore, Md.), 52 2, 578-89 Axelrad J.; Long M.; Horst S.; Afzali A.; Sapir T.; Fajardo K.; De Felice K.; Sandler R.; Cross R. 12-01-2022. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With JMIR Research Protocols, 11 12, O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. 08-01-2016. Update on MR Enterography: Potentials and Pitfalls Current Radiology Reports, 4 8, O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. 08-01-2016. Update on MR Enterography: Potentials and Pitfalls Current Radiology Reports, 4 8, Hemperly A.; Dubinsky M.C.; Yarur A.; Afzali A.; Hanauer S.; Kugathasan S.; Long M.D.; Rabizadeh S.; Sockolow R.; Okada L.; Jain A.; Abreu M.T.; Vande Casteele N. 07-01-2021. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Crohn's and Colitis 360, 3 3, 1-8 Sands B.E.; Irving P.M.; Hoops T.; Izanec J.L.; Gao L.L.; Gasink C.; Greenspan A.; Allez M.; Danese S.; Hanauer S.B.; Jairath V.; Kuehbacher T.; Lewis J.D.; Loftus E.V.; Mihaly E.; Mihaly E.; Panaccione R.; Scherl E.; Shchukina O.B.; Sandborn W.J.; Afzali A.; Aitova L.; Aldeguer i Mante X.; Altorjay I.; Argüelles Arias F.; Armuzzi A.; Augustyn M.; Bafutto M.; Barrio J.; Begun J.; Behrend C.; Bezemer G.; Bonnaud G.; Brankovic M.; Byung I.J.; Calvet Calvo X.; Chachu K.; Chebli J.M.F.; Cheon J.H.; Cichoz-Lach H.; Clark L.; Cummings F.; Dalal K.; De Boer N.; De Lourdes Ferrari M.; Désilets E.; Dugalic P.; Duvall G.; Fedorishina O.; Filip R.; Flores C.; Fogel R.; Fon J.; Frankel M.; Friedenberg K.; Fries W.; Galina V.; Gietka P.; Goel R.; Hasselblatt P.; Herfarth H.; Herszényi L.; Hindryckx P.; Hoentjen F.; Horjus Talabur Horje C.; Iduru S.; Isfort R.; Jones M.; Kalimullina D.; Katz J.; Kaur M.; Khurana S.K.; Kim J.S.; Kim Y.; Kleczkowski D.; Knezevic S.; Knoll A.; Korman L.Y.; Kotzev I.; Kulyapin A.; Lee K.M.; Leemreis D.; Leszczyszyn J.; Limdi J.; Lissauer J.; Loftus E.; Malecka-Panas E.; Marshall J.; Milan L.; Monteleone G.; Nagorni A.; Owczarek D.; Palekar N.; Park Y.S.; Park S.H.; Parra R.; Patai Á.; Patel K.; Patel B.; Pershko A. 06-11-2022. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with The Lancet, 399 10342, 2200-2211 Afzali A.; Carlson C.; Lee S.; Wheat C. 06-01-2012. 31-Year-old male with frequent bleeding and portal vein thrombosis Gastroenterology and Hepatology, 8 6, 8-10 Afzali A.; Carlson C.; Lee S.; Wheat C. 06-01-2012. 31-Year-old male with frequent bleeding and portal vein thrombosis Gastroenterology and Hepatology, 8 6, 8-10 Tiderington E.; Afzali Md A. 05-01-2018. A practical approach to management of the patient with inflammatory bowel disease following tumor ne Journal of Clinical Outcomes Management, 25 5, Tiderington E.; Afzali Md A. 05-01-2018. A practical approach to management of the patient with inflammatory bowel disease following tumor ne Journal of Clinical Outcomes Management, 25 5, Pusateri A.; Anaizi A.; Nemer L.; Hinton A.; Lara L.; Afzali A. 04-01-2022. Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recre Crohn's and Colitis 360, 4 2, Chiorean M.; Afzali A.; Cross R.K.; Macaulay D.; Griffith J.; Wang A.; Garcia-Horton V. 04-01-2020. Economic outcomes of inflammatory bowel disease patients switching to a second anti-tumor necrosis f Crohn's and Colitis 360, 2 2, Danese S.; Panaccione R.; Feagan B.G.; Afzali A.; Rubin D.T.; Sands B.E.; Reinisch W.; Panés J.; Sahoo A.; Terry N.A.; Chan D.; Han C.; Frustaci M.E.; Yang Z.; Sandborn W.J.; Hisamatsu T.; Andrews J.M.; D'Haens G.R.; Oliinyk O.; Bilianskyi L.; Gniady-Jastrzebska J.; Petryka R.; Arlukowicz T.; Gietka P.; Zmudzinski M.; Mumtaz S.; Wolf D.; Wojcik K.; Duvall G.; Augustyn M.; Filip R.; Tarabar D.; Tkachev A.; Seidler U.; Zittan E.; Pokrotnieks J.; Shchukina O.; Machavariani A.; Loy L.; Abu-farsakh N.; Marina P.; Sreckovic S.; Laclav M.; Wei S.C.; Suiter D.; Borsuk A.; Hebuterne X.; Buning C.; Lahat-Zok A.; Danilkiewicz W.; Frysna B.; Jovicic I.; Datsenko O.; Guram M.; Jain A.; Rashid Z.; Heeren S.; Shulga N.; Timkin I.; Gornjakovic S.; Lukas M.; Altwegg R.; Desjeux A.; Reimund J.M.; Giorgadze M.; Jochum C.; Ito H.; Nakai K.; Takagi T.; Zaha O.; Choi C.; Kim T.; Lee J.; Stundiene I.; Hilmi I.N.; Hj Md Said R.; Leszczyszyn J.; Abdulganieva D.; Fominykh Y.; Maksyashina S.; Balaz J.; Van Domselaar M.; Kav T.; Dennis P.; Henry P.; Holmes R.; Johnson C.; McBride M.; Sarles H.; Moore G.; Yakubtsevich R.; Muls V.; Trbojevic S.; Afif W.; Bernstein C.; Klarin I.; Serclova Z.; Volfova M.; Desreumaux P.; Gilletta de Saint Joseph C. 01-01-2023. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results The Lancet Gastroenterology and Hepatology, , Afzali A. 01-01-2019. Update on pregnancy in patients with inflammatory bowel disease Gastroenterology and Hepatology, 15 6, 313-315 Afzali A. 01-01-2019. Update on pregnancy in patients with inflammatory bowel disease Gastroenterology and Hepatology, 15 6, 313-315 Fausel R.; Afzali A.; Afzali A. 01-01-2015. Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon Therapeutics and Clinical Risk Management, 11 , 63-72 Fausel R.; Afzali A.; Afzali A. 01-01-2015. Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon Therapeutics and Clinical Risk Management, 11 , 63-72 Afzali A.; Wheat C.L.; Lee S.D. 01-01-2014. Oral and parenteral corticosteroid therapy in ulcerative colitis Medical Therapy of Ulcerative Colitis, , 111-120 Afzali A.; Wheat C.L.; Lee S.D. 01-01-2014. Oral and parenteral corticosteroid therapy in ulcerative colitis Medical Therapy of Ulcerative Colitis, , 111-120
Afzali, Anita; Lukanova, Rina; Hennessy, Fritha; Kakehi, Sumie; Knight, Hannah; Milligan, Gary; Gupte-Singh, Komal 2023. Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States. Advances in therapy, 40 10, 4321-4338Clement, Benjamin; De Felice, Kara; Afzali, Anita 2023. Indications and safety of newer IBD treatments in the older patient. Current gastroenterology reports, 25 7, 160-168Danese, Silvio; Panaccione, Remo; Abreu, Maria T; Rubin, David T; Ghosh, Subrata; Dignass, Axel; Afzali, Anita; Wolf, Douglas C; Chiorean, Michael V; Vermeire, Severine; Jain, Anjali; Charles, Lorna; Lawlor, Garrett; Osterman, Mark T; Wu, Hsiuanlin; Canavan, James B; Petersen, Ann Katrin; Colombel, Jean-Frederic; Regueiro, Miguel 2023. Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension. Journal of Crohn's & colitis, , Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R 2023. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. The lancet. Gastroenterology & hepatology, , Herfarth, Hans H; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree G; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Long, Millie D 2023. Clinical long-term outcomes of patient-reported outcomes in the prospective real-world Tofacitinib Response in Ulcerative Colitis (TOUR) registry: Tofacitinib Response in Ulcerative Colitis (TOUR). Clinical and translational gastroenterology, , Johnson, Amanda M; Barsky, Maria; Ahmed, Waseem; Zullow, Samantha; Galati, Jonathan; Jairath, Vipul; Narula, Neeraj; Peerani, Farhad; Click, Benjamin H; Coburn, Elliot S; Dang, ThucNhi Tran; Gold, Stephanie; Agrawal, Manasi; Garg, Rajat; Aggarwal, Manik; Mohammad, Danah; Halloran, Brendan; Kochhar, Gursimran S; Todorowski, Hannah; Ud Din, Nabeeha Mohy; Izanec, James; Teeple, Amanda; Gasink, Chris; Muser, Erik; Ding, Zhijie; Swaminath, Arun; Lakhani, Komal; Hogan, Dan; Datta, Samit; Ungaro, Ryan C; Boland, Brigid S; Bohm, Matthew; Fischer, Monika; Sagi, Sashidhar; Afzali, Anita; Ullman, Thomas; Lawlor, Garrett; Baumgart, Daniel C; Chang, Shannon; Hudesman, David; Lukin, Dana; Scherl, Ellen J; Colombel, Jean-Frederic; Sands, Bruce E; Siegel, Corey A; Regueiro, Miguel; Sandborn, William J; Bruining, David; Kane, Sunanda; Loftus, Edward V; Dulai, Parambir S 2023. The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. The American journal of gastroenterology, 118 2, 317-328Long, Millie D; Afzali, Anita; Fischer, Monika; Hudesman, David; Abdalla, Maisa; McCabe, Robert; Cohen, Benjamin L; Ungaro, Ryan C; Harlan, Will; Hanson, John; Konijeti, Gauree; Polyak, Steven; Ritter, Timothy; Salzberg, Bruce; Seminerio, Jennifer; English, Emily; Zhang, Xian; Sharma, Puza P; Herfarth, Hans H 2023. Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Inflammatory bowel diseases, 29 4, 570-578Allen, Kenneth D; Kiefer, Miranda K; Butnariu, Madalina; Afzali, Anita 2022. Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Archives of gynecology and obstetrics, 306 6, 1929-1937Axelrad, Jordan; Long, Millie; Horst, Sara; Afzali, Anita; Sapir, Tamar; Fajardo, Kristina; De Felice, Kara; Sandler, Robert; Cross, Raymond 2022. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols, 11 12, e40382Dulai, Parambir S; Rai, Victoria; Raffals, Laura E; Lukin, Dana; Hudesman, David; Kochhar, Gursimran S; Damas, Oriana M; Sauk, Jenny S; Levy, Alexander N; Sofia, M Anthony; Tuskey, Anne; Deepak, Parakkal; Yarur, Andres J; Afzali, Anita; Ananthakrishnan, Ashwin N; Cross, Raymond K; Hanauer, Stephen B; Siegel, Corey A 2022. Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. The American journal of gastroenterology, 117 8, 1288-1295Feagan, Brian G; Schreiber, Stefan; Afzali, Anita; Rieder, Florian; Hyams, Jeffrey; Kollengode, Kanthi; Pearlman, Jared; Son, Vladimir; Marta, Cecilia; Wolf, Douglas C; D'Haens, Geert G 2022. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program. Contemporary clinical trials, 122 , 106958Neyazi, Narges; Safi, Najibullah; Afzali, Anita; Kabir, Misha 2022. Gender barriers are worsening women's access to health care in Afghanistan. Lancet (London, England), 400 10354, 731-732Pusateri, Antoinette; Anaizi, Ahmad; Nemer, Laura; Hinton, Alice; Lara, Luis; Afzali, Anita 2022. Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis. Crohn's & colitis 360, 4 2, otac015Sandborn, William J; D'Haens, Geert R; Reinisch, Walter; Panés, Julián; Chan, Daphne; Gonzalez, Susana; Weisel, Kathleen; Germinaro, Matthew; Frustaci, Mary Ellen; Yang, Zijiang; Adedokun, Omoniyi J; Han, Chenglong; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; Rubin, David T; Sands, Bruce E; Afzali, Anita; Andrews, Jane M; Feagan, Brian G 2022. Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology, 162 6, 1650-1664.e8Afzali, Anita; Furtner, Daniel; Melsheimer, Richard; Molloy, Philip J 2021. The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable. Advances in therapy, 38 5, 2077-2093Balzora, Sophie; Afzali, Anita; Bewtra, Meenakshi 2021. Social Media-The Next Glass Ceiling? Gastroenterology, 161 1, 373-374Hemperly, Amy; Dubinsky, Marla C; Yarur, Andres; Afzali, Anita; Hanauer, Stephen; Kugathasan, Subra; Long, Millie D; Rabizadeh, Shervin; Sockolow, Robbyn; Okada, Lauren; Jain, Anjali; Abreu, Maria T; Vande Casteele, Niels 2021. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn's & colitis 360, 3 3, otab035Pearlstein, Haley; Bricker, Josh; Michel, Hilary K; Afzali, Anita; Donegan, Amy M; Maltz, Ross M; Boyle, Brendan M; Dotson, Jennifer L 2021. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition, 72 4, 563-568Pusateri, Antoinette; Hatcher, Ashley; Patel, Nisha; Lehman, Joy; Hinton, Alice; Afzali, Anita 2021. Impact of rapid infliximab infusions on access at a large academic tertiary medical center. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 78 22, 2046-2052Rubin, David T; Sninsky, Charles; Siegmund, Britta; Sans, Miquel; Hart, Ailsa; Bressler, Brian; Bouhnik, Yoram; Armuzzi, Alessandro; Afzali, Anita 2021. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey. Inflammatory bowel diseases, 27 12, 1942-1953Syal, Gaurav; Serrano, Mariastella; Jain, Animesh; Cohen, Benjamin L; Rieder, Florian; Stone, Christian; Abraham, Bincy; Hudesman, David; Malter, Lisa; McCabe, Robert; Holubar, Stefan; Afzali, Anita; Cheifetz, Adam S; Gaidos, Jill K J; Moss, Alan C 2021. Health Maintenance Consensus for Adults With Inflammatory Bowel Disease. Inflammatory bowel diseases, 27 10, 1552-1563Chiorean, Michael; Afzali, Anita; Cross, Raymond K; Macaulay, Dendy; Griffith, Jenny; Wang, Anthony; Garcia-Horton, Viviana 2020. Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab. Crohn's & colitis 360, 2 2, otaa031Clark-Snustad, Kindra; Butnariu, Madalina; Afzali, Anita 2020. Women's Health and Ulcerative Colitis. Gastroenterology clinics of North America, 49 4, 769-789McMahon, Kevin R; Allen, Kenneth D; Afzali, Anita; Husain, Syed 2020. Predicting Post-operative Complications in Crohn's Disease: an Appraisal of Clinical Scoring Systems and the NSQIP Surgical Risk Calculator. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 24 1, 88-97Afzali, Anita 2019. Inflammatory bowel disease during pregnancy: management of a disease flare or remission. Current opinion in gastroenterology, 35 4, 281-287Afzali, Anita 2019. Update on Pregnancy in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, 15 6, 313-315Alley, Kristen; Singla, Anand; Afzali, Anita 2019. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Inflammatory bowel diseases, 25 12, 1990-1995Chen, Tong; Shi, Ni; Afzali, Anita 2019. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease. Nutrients, 11 6, Kruger, Andrew J; Hinton, Alice; Afzali, Anita 2019. To the Editors: Index Severity Score and Early Readmission Predicts Increased Mortality in Crohn's Disease Patients. Inflammatory bowel diseases, 25 7, e74-e76Kruger, Andrew J; Hinton, Alice; Afzali, Anita 2019. Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients. Inflammatory bowel diseases, 25 5, 894-901Menon, Tara; Afzali, Anita 2019. Immune-Mediated Colitis. Current treatment options in gastroenterology, 17 4, 506-523Menon, Tara; Afzali, Anita 2019. Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care. The American journal of gastroenterology, 114 9, 1432-1440Sobotka, Lindsay A; Crilley, Tessa; Levine, Edward; Afzali, Anita 2019. Acute Myelogenous Leukemia as a Rare Cause of Duodenal Ulcers. ACG case reports journal, 6 7, e00153Afzali, Anita; Katz, Seymour 2018. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Current treatment options in gastroenterology, 16 3, 289-305Clowse, Megan E B; Scheuerle, Angela E; Chambers, Christina; Afzali, Anita; Kimball, Alexa B; Cush, John J; Cooney, Maureen; Shaughnessy, Laura; Vanderkelen, Mark; Förger, Frauke 2018. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. Arthritis & rheumatology (Hoboken, N.J.), 70 9, 1399-1407Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V 2017. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflammatory bowel diseases, 24 1, 2-4Afzali, Anita; Ogden, Kristine; Friedman, Michael L; Chao, Jingdong; Wang, Anthony 2017. Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting. Journal of medical economics, 20 4, 409-422Afzali, Anita; Sinanan, Mika N; Lee, Scott D 2017. Reply. Inflammatory bowel diseases, 23 1, E3Afzali, Anita; Wahbeh, Ghassan 2017. Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3? World journal of gastroenterology, 23 20, 3624-3631Sandborn, William J; Wolf, Douglas C; Kosutic, Gordana; Parker, Gerry; Schreiber, Stefan; Lee, Scott D; Abraham, Bincy; Afzali, Anita; Arsenescu, Razvan I; Gutierrez, Alexandra; Spearman, Marshall; Coarse, Jason; Feagan, Brian G 2017. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease. Inflammatory bowel diseases, 23 7, 1047-1056Afzali, Anita; Cross, Raymond K 2016. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences. Inflammatory bowel diseases, 22 8, 2023-40Afzali, Anita; Park, Christopher J; Zhu, Kehao; Hu, Jie Kate; Sharma, Prachi; Sinanan, Mika N; Lee, Scott D 2016. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 22 8, 1887-95Fausel, Rebecca; Afzali, Anita 2015. Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists. Therapeutics and clinical risk management, 11 , 63-73Afzali, Anita; Wheat, Chelle L; Hu, Jie Kate; Olerud, John E; Lee, Scott D 2014. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. Journal of Crohn's & colitis, 8 6, 480-8Kelly, Colleen R; Ihunnah, Chioma; Fischer, Monika; Khoruts, Alexander; Surawicz, Christina; Afzali, Anita; Aroniadis, Olga; Barto, Amy; Borody, Thomas; Giovanelli, Andrea; Gordon, Shelley; Gluck, Michael; Hohmann, Elizabeth L; Kao, Dina; Kao, John Y; McQuillen, Daniel P; Mellow, Mark; Rank, Kevin M; Rao, Krishna; Ray, Arnab; Schwartz, Margot A; Singh, Namita; Stollman, Neil; Suskind, David L; Vindigni, Stephen M; Youngster, Ilan; Brandt, Lawrence 2014. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American journal of gastroenterology, 109 7, 1065-71Afzali, Anita; Berry, Kristin; Ioannou, George N 2012. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 18 1, 29-37Wolf, Douglas C; Abraham, Bincy P; Afzali, Anita; Allegretti, Paul D; Arai, Ronen 2012. Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC. Gastroenterology & hepatology, 8 6 Suppl 2, 1-16Afzali, Anita; Weiss, Noel S; Boyko, Edward J; Ioannou, George N 2010. Association between serum uric acid level and chronic liver disease in the United States. Hepatology (Baltimore, Md.), 52 2, 578-89 Axelrad J.; Long M.; Horst S.; Afzali A.; Sapir T.; Fajardo K.; De Felice K.; Sandler R.; Cross R. 12-01-2022. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With JMIR Research Protocols, 11 12, O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. 08-01-2016. Update on MR Enterography: Potentials and Pitfalls Current Radiology Reports, 4 8, O’Malley R.B.; Hansen N.J.; Carnell J.; Afzali A.; Moshiri M. 08-01-2016. Update on MR Enterography: Potentials and Pitfalls Current Radiology Reports, 4 8, Hemperly A.; Dubinsky M.C.; Yarur A.; Afzali A.; Hanauer S.; Kugathasan S.; Long M.D.; Rabizadeh S.; Sockolow R.; Okada L.; Jain A.; Abreu M.T.; Vande Casteele N. 07-01-2021. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Crohn's and Colitis 360, 3 3, 1-8 Sands B.E.; Irving P.M.; Hoops T.; Izanec J.L.; Gao L.L.; Gasink C.; Greenspan A.; Allez M.; Danese S.; Hanauer S.B.; Jairath V.; Kuehbacher T.; Lewis J.D.; Loftus E.V.; Mihaly E.; Mihaly E.; Panaccione R.; Scherl E.; Shchukina O.B.; Sandborn W.J.; Afzali A.; Aitova L.; Aldeguer i Mante X.; Altorjay I.; Argüelles Arias F.; Armuzzi A.; Augustyn M.; Bafutto M.; Barrio J.; Begun J.; Behrend C.; Bezemer G.; Bonnaud G.; Brankovic M.; Byung I.J.; Calvet Calvo X.; Chachu K.; Chebli J.M.F.; Cheon J.H.; Cichoz-Lach H.; Clark L.; Cummings F.; Dalal K.; De Boer N.; De Lourdes Ferrari M.; Désilets E.; Dugalic P.; Duvall G.; Fedorishina O.; Filip R.; Flores C.; Fogel R.; Fon J.; Frankel M.; Friedenberg K.; Fries W.; Galina V.; Gietka P.; Goel R.; Hasselblatt P.; Herfarth H.; Herszényi L.; Hindryckx P.; Hoentjen F.; Horjus Talabur Horje C.; Iduru S.; Isfort R.; Jones M.; Kalimullina D.; Katz J.; Kaur M.; Khurana S.K.; Kim J.S.; Kim Y.; Kleczkowski D.; Knezevic S.; Knoll A.; Korman L.Y.; Kotzev I.; Kulyapin A.; Lee K.M.; Leemreis D.; Leszczyszyn J.; Limdi J.; Lissauer J.; Loftus E.; Malecka-Panas E.; Marshall J.; Milan L.; Monteleone G.; Nagorni A.; Owczarek D.; Palekar N.; Park Y.S.; Park S.H.; Parra R.; Patai Á.; Patel K.; Patel B.; Pershko A. 06-11-2022. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with The Lancet, 399 10342, 2200-2211 Afzali A.; Carlson C.; Lee S.; Wheat C. 06-01-2012. 31-Year-old male with frequent bleeding and portal vein thrombosis Gastroenterology and Hepatology, 8 6, 8-10 Afzali A.; Carlson C.; Lee S.; Wheat C. 06-01-2012. 31-Year-old male with frequent bleeding and portal vein thrombosis Gastroenterology and Hepatology, 8 6, 8-10 Tiderington E.; Afzali Md A. 05-01-2018. A practical approach to management of the patient with inflammatory bowel disease following tumor ne Journal of Clinical Outcomes Management, 25 5, Tiderington E.; Afzali Md A. 05-01-2018. A practical approach to management of the patient with inflammatory bowel disease following tumor ne Journal of Clinical Outcomes Management, 25 5, Pusateri A.; Anaizi A.; Nemer L.; Hinton A.; Lara L.; Afzali A. 04-01-2022. Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recre Crohn's and Colitis 360, 4 2, Chiorean M.; Afzali A.; Cross R.K.; Macaulay D.; Griffith J.; Wang A.; Garcia-Horton V. 04-01-2020. Economic outcomes of inflammatory bowel disease patients switching to a second anti-tumor necrosis f Crohn's and Colitis 360, 2 2, Danese S.; Panaccione R.; Feagan B.G.; Afzali A.; Rubin D.T.; Sands B.E.; Reinisch W.; Panés J.; Sahoo A.; Terry N.A.; Chan D.; Han C.; Frustaci M.E.; Yang Z.; Sandborn W.J.; Hisamatsu T.; Andrews J.M.; D'Haens G.R.; Oliinyk O.; Bilianskyi L.; Gniady-Jastrzebska J.; Petryka R.; Arlukowicz T.; Gietka P.; Zmudzinski M.; Mumtaz S.; Wolf D.; Wojcik K.; Duvall G.; Augustyn M.; Filip R.; Tarabar D.; Tkachev A.; Seidler U.; Zittan E.; Pokrotnieks J.; Shchukina O.; Machavariani A.; Loy L.; Abu-farsakh N.; Marina P.; Sreckovic S.; Laclav M.; Wei S.C.; Suiter D.; Borsuk A.; Hebuterne X.; Buning C.; Lahat-Zok A.; Danilkiewicz W.; Frysna B.; Jovicic I.; Datsenko O.; Guram M.; Jain A.; Rashid Z.; Heeren S.; Shulga N.; Timkin I.; Gornjakovic S.; Lukas M.; Altwegg R.; Desjeux A.; Reimund J.M.; Giorgadze M.; Jochum C.; Ito H.; Nakai K.; Takagi T.; Zaha O.; Choi C.; Kim T.; Lee J.; Stundiene I.; Hilmi I.N.; Hj Md Said R.; Leszczyszyn J.; Abdulganieva D.; Fominykh Y.; Maksyashina S.; Balaz J.; Van Domselaar M.; Kav T.; Dennis P.; Henry P.; Holmes R.; Johnson C.; McBride M.; Sarles H.; Moore G.; Yakubtsevich R.; Muls V.; Trbojevic S.; Afif W.; Bernstein C.; Klarin I.; Serclova Z.; Volfova M.; Desreumaux P.; Gilletta de Saint Joseph C. 01-01-2023. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results The Lancet Gastroenterology and Hepatology, , Afzali A. 01-01-2019. Update on pregnancy in patients with inflammatory bowel disease Gastroenterology and Hepatology, 15 6, 313-315 Afzali A. 01-01-2019. Update on pregnancy in patients with inflammatory bowel disease Gastroenterology and Hepatology, 15 6, 313-315 Fausel R.; Afzali A.; Afzali A. 01-01-2015. Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon Therapeutics and Clinical Risk Management, 11 , 63-72 Fausel R.; Afzali A.; Afzali A. 01-01-2015. Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-? antagon Therapeutics and Clinical Risk Management, 11 , 63-72 Afzali A.; Wheat C.L.; Lee S.D. 01-01-2014. Oral and parenteral corticosteroid therapy in ulcerative colitis Medical Therapy of Ulcerative Colitis, , 111-120 Afzali A.; Wheat C.L.; Lee S.D. 01-01-2014. Oral and parenteral corticosteroid therapy in ulcerative colitis Medical Therapy of Ulcerative Colitis, , 111-120